Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 7124829Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Neurosurgery
NIH Funding · FY2024
Linked Award Amount
$4.7M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#1,206
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing D. Richard Milner as a PI. Multi-PI records show the full award amount for context.
- 1RF1NS136861-01RF1Investigating the Role and the therapeutic potential of Perlecan in experimental vascular dementia$2.6Maward amount
- 1R01DA059344-01A1R01Molecular effects of cannabinoids on the Blood Brain Barrier in HIV-infected brain$779.6Kaward amount
- 4R01NS119477-02R01The protective role of microglia in preventing hypoxic disruption of blood-brain barrier integrity and VCID$741.5Kaward amount
- 1R01NS138923-01R01Evaluating the therapeutic potential of hypoxia mimetics in inflammatory demyelinating disease$647.8Kaward amount
Award organizations
Organizations that administered FY2024 awards listing D. Richard Milner as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardTulane University of Louisiana
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1206
- 2024Entered Top 25% NationallyRanked #1206
- 2024Entered Top 10% NationallyRanked #1206
- 2025$5M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as D. Richard Milner.